Cargando…

Current Role of Prospective Monitoring and Preemptive and Prophylactic Therapy for Human Herpesvirus 6 After Allogeneic Stem Cell Transplantation

Human herpesvirus 6 (HHV-6) frequently reactivates after allogeneic stem cell transplantation (SCT). Most patients are asymptomatic and viremia often resolves without therapy; however, transplant-related complications may be associated with reactivation. Multiple presentations have been attributed t...

Descripción completa

Detalles Bibliográficos
Autor principal:	Handley, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394762/ https://www.ncbi.nlm.nih.gov/pubmed/36004309 http://dx.doi.org/10.1093/ofid/ofac398

Ejemplares similares

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
por: Schmid, Christoph, et al.
Publicado: (2021)

Improving Safety of Preemptive Therapy with Oral Valganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
por: Barkam, Corinna, et al.
Publicado: (2012)

1601. Effect of Preemptive Rituximab Therapy on Epstein–Barr Reactivation in Allogenic Hematopoietic Stem Cell Pediatric Transplants
por: Catho, Gaud, et al.
Publicado: (2018)

Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
por: Noviello, Maddalena, et al.
Publicado: (2023)

Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
por: Navarro, David, et al.
Publicado: (2016)

Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant
por: Chiereghin, Angela, et al.
Publicado: (2021)

Disseminated Toxoplasmosis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report and Review of the Current Literature
por: Baluch, Aliyah, et al.
Publicado: (2022)

Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation
por: Weissinger, E M, et al.
Publicado: (2013)

Perioperative Comparison of Preemptive and Non-Preemptive Renal Transplant Recipients
por: Aytekin, Sami, et al.
Publicado: (2020)

Herpesvirus-Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Meiqing, et al.
Publicado: (2013)

Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience
por: Dzieciątkowski, Tomasz, et al.
Publicado: (2008)

Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients
por: Robin, Christine, et al.
Publicado: (2017)

Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
por: Fan, Shuang, et al.
Publicado: (2022)

Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis
por: Fan, Shuang, et al.
Publicado: (2023)

Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation
por: García-García, Irene, et al.
Publicado: (2021)

Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Claveau, Jean-Sébastien, et al.
Publicado: (2022)

213. Prophylactic oral vancomycin for Clostridioides difficile in allogeneic hematopoietic stem cell transplant recipients
por: Ogawa, Lauren, et al.
Publicado: (2022)

P1560: EARLY DIAGNOSIS WITH EBV MONITOR AND PREEMPTIVE RITUXIMAB REDUCES POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER MORTALITY AND INCREASE OVERALL SURVIVAL AFTER ALLOGENEIC TRANSPLANTATION
por: Liu, Jia-Hau, et al.
Publicado: (2023)

PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
por: Yosra Kanoun, Rimmel, et al.
Publicado: (2023)

Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R ‐Related Leukoencephalopathy
por: Horn, Morten Andreas, et al.
Publicado: (2022)

Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus
por: Wang, Xin, et al.
Publicado: (2021)

Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
por: Gaffney, Kelly J., et al.
Publicado: (2023)

Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt
por: Raouf, May Moheb Eldin, et al.
Publicado: (2023)

51. A Review of Human Herpesvirus 6 and Central Nervous System Disease in Oncology Patients
por: Handley, Guy H, et al.
Publicado: (2020)

Employment and ability to work after kidney transplantation in the Netherlands: The impact of preemptive versus non‐preemptive kidney transplantation
por: Visser, Annemieke, et al.
Publicado: (2022)

Cytomegalovirus monitoring in allogeneic haemopoietic stem cell transplant recipients
por: Ramalingam, S., et al.
Publicado: (2006)

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
por: Blom, Kjersti B., et al.
Publicado: (2023)

Human Herpesvirus-6 Encephalitis After Hematopoietic Stem Cell Transplantation
por: Kasberg-Koniarczyk, Heather L.
Publicado: (2014)

Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy
por: Kim, Tark, et al.
Publicado: (2016)

Co-Infections with Cytomegalovirus and Human Herpesvirus Type 7 in Adult Polish Allogeneic Haematopoietic Stem Cell Transplant Recipients
por: Tomaszewska, Agnieszka, et al.
Publicado: (2013)

Persistent hyperparathyroidism after preemptive kidney transplantation
por: Okada, Manabu, et al.
Publicado: (2023)

Preemptive kidney transplantation: why, when, and how?
por: Moura, Ana Flávia, et al.
Publicado: (2022)

The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.
por: Selby, P. J., et al.
Publicado: (1989)

Epigenetic therapy in allogeneic hematopoietic stem cell transplantation
por: Bashir, Qaiser, et al.
Publicado: (2013)

Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant
por: Gottlieb, David Jonathan, et al.
Publicado: (2021)

Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
por: Castagna, Luca, et al.
Publicado: (2015)

Effects of Social Deprivation on the Proportion of Preemptive Kidney Transplantation: A Mediation Analysis
por: Calvar, Eve, et al.
Publicado: (2021)

Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
por: Atabani, S F, et al.
Publicado: (2012)

Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors
por: Nieuwenhuijs-Moeke, Gertrude J., et al.
Publicado: (2018)

Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation
por: Ueda, Miriam YH, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bp1gnj4qspnv6kbl5unn5dpqad